Definium Therapeutics, Inc. DFTX 深 滬
已收盤 06-18 16:00:00 美东时间
24.48
+0.050
+0.20%
華盛通- 最 高25.2499
- 今 開24.80
- 成交量 262.99万股
- 最 低 23.80
- 昨 收 24.43
- 總市值 26.70亿
- 52周最高 26.25
- 市盈率 靜 --
- 換手率 2.41%
- 52周最低 6.345
- 委 比 -63.54%
- 總股本 1.09亿
- 歷史最高 86.55
- 量 比 1.59
- 振 幅 5.93%
- 歷史最低 2.20
- 每 手 1
- 風險率 5.10%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 爱彼迎、Affirm、CoreWeave、Datadog、微芯科技等获多家大行上调目标价；HubSpot惨遭14家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Artiva Biotherapeutics"买入"评级，目标价从15美元升至35美元；韦德布什：维持Cullinan Therapeutics"跑赢大市"评级，目标价从36美元升至37美元
05-11 15:43
'Health Officials Close To U.S. Secretary Kennedy Explored Ban Of Some Widely Used Antidepressants' - Reuters Exclusive
Health officials explored restricting specific antidepressants among SSRI drugs-sourcesKennedy announced other steps to reduce use of the medicines on MondayKennedy says SSRIs are overprescribed and, without evidence,
05-09 00:02
Piper Sandler Maintains Overweight on Definium Therapeutics, Lowers Price Target to $48
Piper Sandler analyst David Amsellem maintains Definium Therapeutics (NASDAQ:DFTX) with a Overweight and lowers the price target from $49 to $48.
05-08 23:05
Definium Therapeutics Q1 EPS $(0.71) Misses $(0.48) Estimate. Cash And Equivalents Of $373.4M
Definium Therapeutics (NASDAQ:DFTX) reported quarterly losses of $(0.71) per share which missed the analyst consensus estimate of $(0.48) by 47.92 percent. This is a 102.86 percent decrease over losses of $(0.35) per
05-08 04:09
9 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. ...
04-25 01:35
Definium Therapeutics (DFTX) Stock Gains After Hours: Here's What's Driving The Move
Definium Therapeutics stock rises after hours amid psychedelic sector rally following Trump's regulatory push.
04-21 15:44
Enveric BioSciences Surges Over 90%, Other Psychedelic Stocks Soar In Monday Pre-Market: What's Going On?
Psychedelic drug maker shares jumped in Monday pre-market after an order from President Donald Trump to speed up psychedelic drug reviews
04-20 20:35
美股大行评级 | 美银证券上调闪迪目标价从900美元升至1080美元；纽约梅隆银行、Onto Innovation、安博、美国合众银行等获多家大行上调目标价
今日重点评级关注：Guggenheim：维持AtaiBeckley Inc."买入"评级，目标价从11美元升至16美元；RBC Capital：维持MeiraGTx Holdings"跑赢大市"评级，目标价从16美元升至24美元
04-20 11:33
Definium Therapeutics Anxiety Drug A Multi-Billion Opportunity: Analyst
Stifel starts Definium coverage, citing strong DT120 potential in anxiety and key 2026 trial catalysts shaping outlook.
04-18 02:06
美股大行评级 | 美国银行、摩根士丹利、JB亨特运输服务、PNC金融服务、Cheniere Energy等获多家大行上调目标价
今日重点评级关注：HC Wainwright & Co.：维持FibroBiologics"买入"评级，目标价从4美元升至8美元；摩根士丹利：维持Ultragenyx药业"超配"评级，目标价从50美元升至67美元
04-17 11:27
